Ellen Wempe

485 total citations
28 papers, 366 citations indexed

About

Ellen Wempe is a scholar working on Molecular Biology, Infectious Diseases and Organic Chemistry. According to data from OpenAlex, Ellen Wempe has authored 28 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 8 papers in Infectious Diseases and 8 papers in Organic Chemistry. Recurrent topics in Ellen Wempe's work include Phenothiazines and Benzothiazines Synthesis and Activities (8 papers), HIV/AIDS drug development and treatment (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Ellen Wempe is often cited by papers focused on Phenothiazines and Benzothiazines Synthesis and Activities (8 papers), HIV/AIDS drug development and treatment (7 papers) and Pneumocystis jirovecii pneumonia detection and treatment (6 papers). Ellen Wempe collaborates with scholars based in Germany, Chile and Switzerland. Ellen Wempe's co-authors include Joachim K. Seydel, Hans Peter Cordes, Wolfram Hänsel, Klaus‐Jürgen Schaper, Klaus Schaper, Rainer Bartels, George H. Miller, Ekkehard Krüger‐Thiemer, M. Richter and Linda Miller and has published in prestigious journals such as Journal of Medicinal Chemistry, The Journal of Infectious Diseases and Journal of Pharmaceutical Sciences.

In The Last Decade

Ellen Wempe

26 papers receiving 334 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ellen Wempe Germany 8 175 98 73 57 55 28 366
Bertil Ekström Sweden 11 166 0.9× 165 1.7× 38 0.5× 143 2.5× 62 1.1× 27 513
Hideo Nakao Japan 11 162 0.9× 119 1.2× 20 0.3× 89 1.6× 32 0.6× 37 342
Marland P. Hutt United States 11 340 1.9× 338 3.4× 32 0.4× 165 2.9× 47 0.9× 20 601
Kohji Kawabata Japan 12 349 2.0× 239 2.4× 37 0.5× 124 2.2× 46 0.8× 29 551
D. Bouzard France 12 337 1.9× 224 2.3× 29 0.4× 99 1.7× 24 0.4× 33 485
M. ESSIZ France 9 210 1.2× 135 1.4× 19 0.3× 74 1.3× 15 0.3× 18 323
James Clayton United Kingdom 13 220 1.3× 158 1.6× 28 0.4× 171 3.0× 34 0.6× 26 463
Sanja Koštrun Croatia 14 226 1.3× 191 1.9× 41 0.6× 44 0.8× 51 0.9× 26 478
T. F. MICH United States 8 229 1.3× 260 2.7× 18 0.2× 139 2.4× 32 0.6× 12 430
F. P. Doyle Ireland 6 110 0.6× 129 1.3× 43 0.6× 148 2.6× 16 0.3× 7 372

Countries citing papers authored by Ellen Wempe

Since Specialization
Citations

This map shows the geographic impact of Ellen Wempe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ellen Wempe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ellen Wempe more than expected).

Fields of papers citing papers by Ellen Wempe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ellen Wempe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ellen Wempe. The network helps show where Ellen Wempe may publish in the future.

Co-authorship network of co-authors of Ellen Wempe

This figure shows the co-authorship network connecting the top 25 collaborators of Ellen Wempe. A scholar is included among the top collaborators of Ellen Wempe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ellen Wempe. Ellen Wempe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rosenfeld, Morris, et al.. (1986). In vitro activity of the new quinoline derivative ciprofloxacin alone and in combination against various Mycobacterium-, Salmonella- and Escherichia coli strains.. PubMed. 36(6). 904–12. 2 indexed citations
3.
Seydel, Joachim K. & Ellen Wempe. (1980). Bacterial Growth Kinetics of <i>E. coli</i> in the Presence of Various Trimethoprim Derivatives Alone and in Combination with Sulfonamides. Chemotherapy. 26(5). 361–371. 5 indexed citations
4.
5.
Seydel, Joachim K., Klaus Schaper, Ellen Wempe, & Hans Peter Cordes. (1976). Mode of action and quantitative structure-activity correlations of tuberculostatic drugs of the isonicotinic acid hydrazide type. Journal of Medicinal Chemistry. 19(4). 483–492. 64 indexed citations
6.
Seydel, Joachim K., et al.. (1976). [Pharmacokinetic studies with the combination sulfamoxole/trimethoprim in animals and men (author's transl)].. PubMed. 26(42). 651–7. 6 indexed citations
7.
Seydel, Joachim K. & Ellen Wempe. (1975). Kinetics and Mechanisms of Action of ‘Folate Synthesis Inhibitors’, Alone or in Combination, on <i>Escherichia coli</i>. Chemotherapy. 21(3-4). 131–145. 3 indexed citations
8.
Seydel, Joachim K., Ellen Wempe, George H. Miller, & Linda Miller. (1973). Quantification of the Antibacterial Action of Trimethoprim Alone and in Combination with Sulfonamides by Bacterial Growth Kinetics. The Journal of Infectious Diseases. 128(Supplement 3). S463–S469. 11 indexed citations
9.
Seydel, Joachim K., et al.. (1972). Kinetics and Mechanisms of Action of Trimethoprim and Sulfonamides, Alone or in Combination, upon <i>Escherichia coli</i> (Part 1 of 2). Chemotherapy. 17(4). 217–237. 25 indexed citations
10.
Seydel, Joachim K., et al.. (1972). Kinetics and Mechanisms of Action of Trimethoprim and Sulfonamides, Alone or in Combination, upon <i>Escherichia coli</i> (Part 2 of 2). Chemotherapy. 17(4). 238–258. 35 indexed citations
11.
Cammarata, Arthur, Richard C. Allen, Joachim K. Seydel, & Ellen Wempe. (1970). Cautions Regarding the Physical Interpretation of Statistically Based Structure—Activity Relationships. Journal of Pharmaceutical Sciences. 59(10). 1496–1499. 5 indexed citations
12.
Krüger‐Thiemer, Ekkehard, Heather A. Berlin, G. Brante, et al.. (1969). Dosage Regimen Calculation of Chemotherapeutic Agents. Chemotherapy. 14(5). 273–302. 7 indexed citations
13.
Krüger‐Thiemer, Ekkehard, et al.. (1967). Dosage Regimen Calculation of Chemotherapeutic Agents. Part IV. 5-Sulfanilamido-1-ethyl-pyrazole. Chemotherapy. 12(6). 321–337. 1 indexed citations
14.
Krüger‐Thiemer, Ekkehard, et al.. (1965). Dosage Regimen Calculation of Chemotherapeutic Agents. Part. III Sulfasymazine. Chemotherapy. 10(6). 325–338. 6 indexed citations
15.
Seydel, Joachim K., et al.. (1963). Zur Toxicit�t des Sulfaphenylpyrazols. Journal of Molecular Medicine. 41(21). 1067–1068. 4 indexed citations
16.
Seydel, Joachim K., et al.. (1963). [Structure and action of carbothionamides. 2].. PubMed. 13. 200–5. 1 indexed citations
17.
Seydel, Joachim K., et al.. (1962). [Relation between the structure and action of carbothpowmide].. PubMed. 12. 127–33. 1 indexed citations
18.
Seydel, Joachim K., Ekkehard Krüger‐Thiemer, & Ellen Wempe. (1960). Beziehungen zwischen der antibakteriellen Wirkung und den Infrarot- (IR-) Absorptionsbanden von Sulfanilamiden. Zeitschrift für Naturforschung B. 15(10). 628–641. 7 indexed citations
19.
Wempe, Ellen, et al.. (1955). Zur quantitativen Bestimmung der Thiobarbitursäuren. Archiv der Pharmazie. 288(1). 1–6. 4 indexed citations
20.
Wempe, Ellen, et al.. (1954). [A reliable determination of isoniazid in the urine. II..].. PubMed. 4(4). 294–5. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Bertil Ekström Breakdown of academic impact, for papers by Hideo Nakao Breakdown of academic impact, for papers by Marland P. Hutt Breakdown of academic impact, for papers by Kohji Kawabata Breakdown of academic impact, for papers by D. Bouzard Breakdown of academic impact, for papers by M. ESSIZ Breakdown of academic impact, for papers by James Clayton Breakdown of academic impact, for papers by Sanja Koštrun Breakdown of academic impact, for papers by T. F. MICH Breakdown of academic impact, for papers by F. P. Doyle
Rankless by CCL
2026